Published in Law and Health Weekly, January 27th, 2007
The formal submission of the MAA is expected in the early part of Q1 2007. Bioenvision continues to expect a decision on this regulatory filing in calendar 2007.
"We are taking the appropriate steps to aggressively, but...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.